Literature DB >> 19162308

Molecular interactions in cancer cell metastasis.

Susan A Brooks1, Hannah J Lomax-Browne, Tracey M Carter, Chloe E Kinch, Debbie M S Hall.   

Abstract

Metastasis, the process by which cancer cells leave the primary tumour, disseminate and form secondary tumours at anatomically distant sites, is a serious clinical problem as it is disseminated disease, which is often impossible to eradicate successfully, that causes the death of most cancer patients. Metastasis results from a complex molecular cascade comprising many steps, all of which are interconnected through a series of adhesive interactions and invasive processes as well as responses to chemotactic stimuli. In spite of its clinical significance, it remains incompletely understood. This review provides an overview of some of the molecular interactions that are critical to metastasis. It summarises the principle molecular players in the major steps of the metastatic cascade. These are: (1) tumour angiogenesis, (2) disaggregation of tumour cells from the primary tumour mass, mediated by cadherins and catenins, (3) invasion of, and migration through, the basement membrane (BM) and extracellular matrix (ECM) surrounding the tumour epithelium, and subsequent invasion of the BM of the endothelium of local blood vessels. This is mediated through integrins and proteases, including urokinase form of plasminogen activator (uPA), matrix metalloproteinases (MMPs) and cathepsins, (4) intravasation of the tumour cells into the blood vessels prior to hematogeneous dissemination to distant sites, (5) adhesion of the circulating tumour cells to the endothelial cell lining at the capillary bed of the target organ site. This occurs through adhesive interactions between cancer cells and endothelial cells involving selectins, integrins and members of the immunoglobulin superfamily (IgSF), (6) invasion of the tumour cells through the endothelial cell layer and surrounding BM (extravasation) and target organ tissue and (7) the development of secondary tumour foci at the target organ site. 2008 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162308     DOI: 10.1016/j.acthis.2008.11.022

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  87 in total

1.  Beta-catenin inhibits melanocyte migration but induces melanoma metastasis.

Authors:  S J Gallagher; F Rambow; M Kumasaka; D Champeval; A Bellacosa; V Delmas; L Larue
Journal:  Oncogene       Date:  2012-06-04       Impact factor: 9.867

2.  The transcription factor EGR1 regulates metastatic potential of v-src transformed sarcoma cells.

Authors:  Vladimír Cermák; Jan Kosla; Jirí Plachý; Katerina Trejbalová; Jirí Hejnar; Michal Dvorák
Journal:  Cell Mol Life Sci       Date:  2010-05-28       Impact factor: 9.261

Review 3.  Liver metastases: Microenvironments and ex-vivo models.

Authors:  Amanda M Clark; Bo Ma; D Lansing Taylor; Linda Griffith; Alan Wells
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

Review 4.  Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.

Authors:  Dimitra Bourboulia; William G Stetler-Stevenson
Journal:  Semin Cancer Biol       Date:  2010-05-12       Impact factor: 15.707

Review 5.  Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.

Authors:  Moustafa Elhousiny; Kate Miller; Anura Ariyawadana; Alan Nimmo
Journal:  Clin Exp Metastasis       Date:  2019-09-26       Impact factor: 5.150

6.  Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells.

Authors:  Manohar C Dange; Nithya Srinivasan; Shyam K More; Sanjay M Bane; Archana Upadhya; Arvind D Ingle; Rajiv P Gude; Rabindranath Mukhopadhyaya; Rajiv D Kalraiya
Journal:  Clin Exp Metastasis       Date:  2014-06-21       Impact factor: 5.150

7.  EILDV-conjugated, etoposide-loaded biodegradable polymeric micelles directing to tumor metastatic cells overexpressing α4β1 integrin.

Authors:  Mukesh Ukawala; Tushar Rajyaguru; Kiran Chaudhari; A S Manjappa; R S R Murthy; Rajiv Gude
Journal:  Cancer Nanotechnol       Date:  2011-09-15

8.  Reactive oxygen species and tumor metastasis.

Authors:  Doo Jae Lee; Sang Won Kang
Journal:  Mol Cells       Date:  2013-02-21       Impact factor: 5.034

9.  Downregulation of uPAR and cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas.

Authors:  Ramarao Malla; Sreelatha Gopinath; Kiranmai Alapati; Christopher S Gondi; Meena Gujrati; Dzung H Dinh; Sanjeeva Mohanam; Jasti S Rao
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

10.  Suppression of uPAR retards radiation-induced invasion and migration mediated by integrin β1/FAK signaling in medulloblastoma.

Authors:  Arun Kumar Nalla; Swapna Asuthkar; Praveen Bhoopathi; Meena Gujrati; Dzung H Dinh; Jasti S Rao
Journal:  PLoS One       Date:  2010-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.